En route towards a personalized medicine approach: Innovative therapeutic modalities for connective tissue disorders
出版年份 2023 全文链接
标题
En route towards a personalized medicine approach: Innovative therapeutic modalities for connective tissue disorders
作者
关键词
-
出版物
MATRIX BIOLOGY
Volume 122, Issue -, Pages 46-54
出版商
Elsevier BV
发表日期
2023-08-30
DOI
10.1016/j.matbio.2023.08.005
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RNA editing: Expanding the potential of RNA therapeutics
- (2023) Brian J. Booth et al. MOLECULAR THERAPY
- Duchenne Muscular Dystrophy Gene Therapy in 2023: Status, Perspective, and Beyond
- (2023) Dongsheng Duan HUMAN GENE THERAPY
- ‘It’s a vote for hope’: first gene therapy for muscular dystrophy nears approval, but will it work?
- (2023) Sara Reardon NATURE
- Dystrophin Immunity after Gene Therapy for Duchenne’s Muscular Dystrophy
- (2023) Carsten G. Bönnemann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemistry, structure and function of approved oligonucleotide therapeutics
- (2023) Martin Egli et al. NUCLEIC ACIDS RESEARCH
- Prime editing: advances and therapeutic applications
- (2023) Zhihan Zhao et al. TRENDS IN BIOTECHNOLOGY
- The Human Extracellular Matrix Diseasome Reveals Genotype–Phenotype Associations with Clinical Implications for Age-Related Diseases
- (2023) Cyril Statzer et al. Biomedicines
- 4‐PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta
- (2022) Ivan Duran et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Oligonucleotide Therapeutics: From Discovery and Development to Patentability
- (2022) Lara Moumné et al. Pharmaceutics
- 4PBA reduces growth deficiency in osteogenesis imperfecta by enhancing transition of hypertrophic chondrocytes to osteoblasts
- (2022) Amanda L. Scheiber et al. JCI Insight
- Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
- (2022) Johannes Bischof et al. MOLECULAR THERAPY
- AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice
- (2022) Jiaming Wang et al. NATURE
- In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial
- (2022) Irina Gurevich et al. NATURE MEDICINE
- CRISPR/Cas gene editing in the human germline
- (2022) B. Bekaert et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Amelioration of muscle and nerve pathology of Lama2-related dystrophy by AAV9-laminin-αLN-linker protein
- (2022) Karen K. McKee et al. JCI Insight
- NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough
- (2022) Kohei Omachi et al. iScience
- Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa
- (2022) Shireen V. Guide et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolving AAV-delivered therapeutics towards ultimate cures
- (2021) Xiangjun He et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Therapeutic promise of engineered nonsense suppressor tRNAs
- (2021) Joseph J. Porter et al. Wiley Interdisciplinary Reviews-RNA
- Nonsense suppression therapies in human genetic diseases
- (2021) Patrícia Martins-Dias et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
- (2021) Michael Ablinger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52
- (2021) Jessica M. Cale et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta
- (2021) Nadia Garibaldi et al. MATRIX BIOLOGY
- Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction
- (2021) Manish Muhuri et al. Frontiers in Immunology
- Base editing repairs an SGCA mutation in human primary muscle stem cells
- (2021) Helena Escobar et al. JCI Insight
- Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases
- (2021) Hyewon Jang et al. Nature Biomedical Engineering
- Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders
- (2021) Lara Marrone et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
- (2021) Craig M McDonald et al. Journal of Comparative Effectiveness Research
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia
- (2020) Monica Borgatti et al. Journal of Clinical Medicine
- Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy
- (2020) Kasia Dzierlega et al. GENE THERAPY
- Laminin-111 protein therapy after disease onset slows muscle disease in a mouse model of Laminin-α2 related congenital muscular dystrophy
- (2020) Pamela Barraza-Flores et al. HUMAN MOLECULAR GENETICS
- Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
- (2020) Tomohiko Yamamura et al. Nature Communications
- Viltolarsen: First Approval
- (2020) Sohita Dhillon DRUGS
- The delivery challenge: fulfilling the promise of therapeutic genome editing
- (2020) Joost van Haasteren et al. NATURE BIOTECHNOLOGY
- Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy
- (2020) Jerry R. Mendell et al. JAMA Neurology
- Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
- (2020) Pamela Barraza-Flores et al. Skeletal Muscle
- The fibrillin microfibril/elastic fibre network: A critical extracellular supramolecular scaffold to balance skin homoeostasis
- (2020) Christin S. Adamo et al. EXPERIMENTAL DERMATOLOGY
- The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup
- (2020) Philip J. Brooks et al. HUMAN GENE THERAPY
- Epidermolysis bullosa
- (2020) Ajoy Bardhan et al. Nature Reviews Disease Primers
- Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos
- (2020) Michael V. Zuccaro et al. CELL
- In vivo RNA editing of point mutations via RNA-guided adenosine deaminases
- (2019) Dhruva Katrekar et al. NATURE METHODS
- Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy
- (2019) Kay E. Davies et al. MOLECULAR THERAPY
- COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity
- (2019) Cassandre Labelle-Dumais et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The role of fibrillin and microfibril binding proteins in elastin and elastic fibre assembly
- (2019) Alan R.F. Godwin et al. MATRIX BIOLOGY
- A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene
- (2019) Dwi U. Kemaladewi et al. NATURE
- Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
- (2019) Allison M. Keeler et al. Annual Review of Virology
- Muscular dystrophies
- (2019) Eugenio Mercuri et al. LANCET
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
- (2019) Jinkuk Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane
- (2018) Steven D. Funk et al. MATRIX BIOLOGY
- Eteplirsen treatment for Duchenne muscular dystrophy
- (2018) Jay S. Charleston et al. NEUROLOGY
- Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin
- (2018) Chunping Qiao et al. Molecular Therapy-Methods & Clinical Development
- LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes
- (2018) Jorge Oliveira et al. HUMAN MUTATION
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- Phenotypic Spectrum of Epidermolysis Bullosa: The Paradigm of Syndromic Versus Non-Syndromic Skin Fragility Disorders
- (2018) Hassan Vahidnezhad et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inosine induces context-dependent recoding and translational stalling
- (2018) Konstantin Licht et al. NUCLEIC ACIDS RESEARCH
- Different Forms of ER Stress in Chondrocytes Result in Short Stature Disorders and Degenerative Cartilage Diseases: New Insights by Cartilage-Specific ERp57 Knockout Mice
- (2018) Yvonne Rellmann et al. Oxidative Medicine and Cellular Longevity
- Recapitulating and Correcting Marfan Syndrome in a Cellular Model
- (2017) Jung Woo Park et al. International Journal of Biological Sciences
- The provisional matrix: setting the stage for tissue repair outcomes
- (2017) Thomas H. Barker et al. MATRIX BIOLOGY
- Provisional matrix: A role for versican and hyaluronan
- (2017) Thomas N. Wight MATRIX BIOLOGY
- Regeneration of the entire human epidermis using transgenic stem cells
- (2017) Tobias Hirsch et al. NATURE
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- RNA editing with CRISPR-Cas13
- (2017) David B. T. Cox et al. SCIENCE
- Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine
- (2016) Maximilian W. Popp et al. CELL
- Eteplirsen: First Global Approval
- (2016) Yahiya Y. Syed DRUGS
- An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death
- (2016) Alessandra Granata et al. NATURE GENETICS
- Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa
- (2016) Jeroen Bremer et al. Molecular Therapy-Nucleic Acids
- Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls
- (2015) Delphine Trochet et al. CURRENT GENE THERAPY
- Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3
- (2015) Bijoyita Roy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ataluren: First Global Approval
- (2014) Nicola J. Ryan DRUGS
- Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
- (2014) Rajat M. Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
- (2014) C. Long et al. SCIENCE
- Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
- (2014) Steven Lin et al. eLife
- Dystrophin levels and clinical severity in Becker muscular dystrophy patients
- (2013) J. C. van den Bergen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Ehlers–Danlos syndrome: A showcase of conditions that lead to understanding matrix biology
- (2013) Peter H. Byers et al. MATRIX BIOLOGY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Integrin α3Mutations with Kidney, Lung, and Skin Disease
- (2012) Cristina Has et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
- (2011) M. Wilschanski et al. EUROPEAN RESPIRATORY JOURNAL
- Transgenic overexpression of the 7 integrin reduces muscle pathology and improves viability in the dyW mouse model of merosin-deficient congenital muscular dystrophy type 1A
- (2011) J. A. Doe et al. JOURNAL OF CELL SCIENCE
- Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy
- (2010) Vinod Malik et al. ANNALS OF NEUROLOGY
- The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
- (2010) Michael R. Lieber Annual Review of Biochemistry
- Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
- (2010) Richard S. Finkel JOURNAL OF CHILD NEUROLOGY
- The revised Ghent nosology for the Marfan syndrome
- (2010) B. L. Loeys et al. JOURNAL OF MEDICAL GENETICS
- A Duchenne Muscular Dystrophy Gene Hot Spot Mutation in Dystrophin-Deficient Cavalier King Charles Spaniels Is Amenable to Exon 51 Skipping
- (2010) Gemma L. Walmsley et al. PLoS One
- Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo
- (2009) Nicole K. Paulk et al. HEPATOLOGY
- Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase
- (2009) Sylvie Tuffery-Giraud et al. HUMAN MUTATION
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
- (2009) Roberto Calcedo et al. JOURNAL OF INFECTIOUS DISEASES
- First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder
- (2009) Sancy A Leachman et al. MOLECULAR THERAPY
- Protein Trans-Splicing as a Means for Viral Vector-Mediated In Vivo Gene Therapy
- (2008) Juan Li et al. HUMAN GENE THERAPY
- A meta-analysis of nonsense mutations causing human genetic disease
- (2008) Matthew Mort et al. HUMAN MUTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now